Lehmann S, Vialaret J, Gabelle A, Bauchet L, Villemin J, Hirtz C
Bioinformatics. 2024; 40(8).
PMID: 39078204
PMC: 11335370.
DOI: 10.1093/bioinformatics/btae484.
Jack Jr C, Scott Andrews J, Beach T, Buracchio T, Dunn B, Graf A
Alzheimers Dement. 2024; 20(8):5143-5169.
PMID: 38934362
PMC: 11350039.
DOI: 10.1002/alz.13859.
Masato A, Andolfo A, Favetta G, Bellini E, Cogo S, Dalla Valle L
Cell Death Dis. 2024; 15(6):424.
PMID: 38890356
PMC: 11189528.
DOI: 10.1038/s41419-024-06763-x.
Giroux P, Vialaret J, Kindermans J, Gabelle A, Bauchet L, Hirtz C
J Proteome Res. 2024; 23(7):2408-2418.
PMID: 38857467
PMC: 11232576.
DOI: 10.1021/acs.jproteome.4c00059.
Iqbal I, Saqib F, Mubarak Z, Latif M, Wahid M, Nasir B
Eur J Med Res. 2024; 29(1):313.
PMID: 38849950
PMC: 11161981.
DOI: 10.1186/s40001-024-01915-3.
Cell autonomous microglia defects in a stem cell model of frontotemporal dementia.
Iyer A, Vermunt L, Mirfakhar F, Minaya M, Acquarone M, Koppisetti R
medRxiv. 2024; .
PMID: 38798451
PMC: 11118656.
DOI: 10.1101/2024.05.15.24307444.
Relationship of Sleep Disorder with Neurodegenerative and Psychiatric Diseases: An Updated Review.
Xiao X, Rui Y, Jin Y, Chen M
Neurochem Res. 2023; 49(3):568-582.
PMID: 38108952
DOI: 10.1007/s11064-023-04086-5.
Structure-Based Discovery of A Small Molecule Inhibitor of Histone Deacetylase 6 (HDAC6) that Significantly Reduces Alzheimer's Disease Neuropathology.
Mondal P, Bai P, Gomm A, Bakiasi G, Lin C, Wang Y
Adv Sci (Weinh). 2023; 11(1):e2304545.
PMID: 37990786
PMC: 10767396.
DOI: 10.1002/advs.202304545.
Tau truncation in the pathogenesis of Alzheimer's disease: a narrative review.
Chu D, Yang X, Wang J, Zhou Y, Gu J, Miao J
Neural Regen Res. 2023; 19(6):1221-1232.
PMID: 37905868
PMC: 11467920.
DOI: 10.4103/1673-5374.385853.
Diagnostic and therapeutic targeting of pathological tau proteins in neurodegenerative disorders.
Sahara N, Higuchi M
FEBS Open Bio. 2023; 14(2):165-180.
PMID: 37746832
PMC: 10839408.
DOI: 10.1002/2211-5463.13711.
Traumatic brain injury and the pathways to cerebral tau accumulation.
Flavin W, Hosseini H, Ruberti J, Kavehpour H, Giza C, Prins M
Front Neurol. 2023; 14:1239653.
PMID: 37638180
PMC: 10450935.
DOI: 10.3389/fneur.2023.1239653.
Frontotemporal lobar degeneration.
Grossman M, Seeley W, Boxer A, Hillis A, Knopman D, Ljubenov P
Nat Rev Dis Primers. 2023; 9(1):40.
PMID: 37563165
DOI: 10.1038/s41572-023-00447-0.
Heterogenous Genetic, Clinical, and Imaging Features in Patients with Neuronal Intranuclear Inclusion Disease Carrying Repeat Expansion.
Fitrah Y, Higuchi Y, Hara N, Tokutake T, Kanazawa M, Sanpei K
Brain Sci. 2023; 13(6).
PMID: 37371433
PMC: 10296744.
DOI: 10.3390/brainsci13060955.
Blood biomarkers for Alzheimer's disease in clinical practice and trials.
Hansson O, Blennow K, Zetterberg H, Dage J
Nat Aging. 2023; 3(5):506-519.
PMID: 37202517
PMC: 10979350.
DOI: 10.1038/s43587-023-00403-3.
Protein kinetics of superoxide dismutase-1 in familial and sporadic amyotrophic lateral sclerosis.
Ly C, Ireland M, Self W, Bollinger J, Jockel-Balsarotti J, Herzog H
Ann Clin Transl Neurol. 2023; 10(6):1012-1024.
PMID: 37119480
PMC: 10270254.
DOI: 10.1002/acn3.51784.
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's disease.
Barthelemy N, Saef B, Li Y, Gordon B, He Y, Horie K
Nat Aging. 2023; 3(4):391-401.
PMID: 37117788
PMC: 10154225.
DOI: 10.1038/s43587-023-00380-7.
Tau-targeting antisense oligonucleotide MAPT in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.
Mummery C, Borjesson-Hanson A, Blackburn D, Vijverberg E, De Deyn P, Ducharme S
Nat Med. 2023; 29(6):1437-1447.
PMID: 37095250
PMC: 10287562.
DOI: 10.1038/s41591-023-02326-3.
The glymphatic system: Current understanding and modeling.
Bohr T, Hjorth P, Holst S, Hrabetova S, Kiviniemi V, Lilius T
iScience. 2022; 25(9):104987.
PMID: 36093063
PMC: 9460186.
DOI: 10.1016/j.isci.2022.104987.
Identification and characterization of a MAPT-targeting locked nucleic acid antisense oligonucleotide therapeutic for tauopathies.
Easton A, Jensen M, Wang C, Hagedorn P, Li Y, Weed M
Mol Ther Nucleic Acids. 2022; 29:625-642.
PMID: 36090761
PMC: 9424863.
DOI: 10.1016/j.omtn.2022.07.027.
Different AT(N) profiles and clinical progression classified by two different N markers using total tau and neurofilament light chain in cerebrospinal fluid.
Kasuga K, Kikuchi M, Tsukie T, Suzuki K, Ihara R, Iwata A
BMJ Neurol Open. 2022; 4(2):e000321.
PMID: 36046332
PMC: 9379489.
DOI: 10.1136/bmjno-2022-000321.
